CEBIPHAR updates

CEBIPHAR Toulouse : Opening of a pharmaceutical establishment

23/06/2021

Share:

CEBIPHAR gets authorization from ANSM and ANSES for the opening of a pharmaceutical establishment on Toulouse site

We are pleased to announce that after the launch of the CEBIPHAR Toulouse site in March 2019, we received the authorization to open a pharmaceutical establishment from the ANSM (French Human Health Agency) in July 2020 and from the ANSES (French Veterinary Health Agency) in September 2020. In order to obtain the GMP certification, the first inspection by the ANSES took place in Toulouse
in April 2021.

This allows us to achieve the 2 objectives that CEBIPHAR set for itself when creating this second site, namely:

In addition to its technical expertise, CEBIPHAR’s operational teams place a high priority on customer service, proximity and availability. CEBIPHAR is able to adapt its organization specifically to your project.

SUGGESTIONS FOR SCIENTIFIC TOPICS

Other news that might interest you

CEBIPHAR updates

CPHi : The leading event...

Bringing together thousands of providers and players from the pharmaceutical industry across the supply chain, CPhI Worldwide is the best platform to search for...
Read the article
CEBIPHAR updates

WITH 94% OF CLIENT SATISFACTION...

As part of our sustainable customer experience program, a customer satisfaction survey was conducted in June 2021, aiming to build long-term relationships with our...
Read the article
CEBIPHAR updates

CEBIPHAR awarded with a contract...

The French government recovery plan: Several pharma companies are focused on providing solutions to meet the needs of hospitals for essential drugs The pandemic...
Read the article
Nous pouvons vous accompagner dans le développement et le contrôle de vos produits
Contact Nous pouvons vous accompagner dans le développement et le contrôle de vos produits Discuter avec l'un de nos scientifiques
STAY TUNED

The main objective of our Newsletter is to focus on one of our services by showing the added value it can bring you.

Newsletter Fr